This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
After more than 15 years, the battle between the Canada Revenue Agency and Glaxo Canada over the transfer price for ranitidine—the active pharmaceutical ingredient used to make the branded, anti-ulcer drug Zantac—finally reached the Supreme Court of Canada (SCC) last month.
In the United States, 2025 brought major activity in high profile transfer pricing disputes and reaffirmed how closely transfer pricing, tariffs, and customs...
“We are excited to welcome Arin to CRA,” said Paul Maleh, President and Chief Executive Officer of Charles River Associates. “He has more than three decades of...
CRA is a proud sponsor of the event providing invaluable opportunities for collaboration, learning and engagement. Attendees will connect with 300+ tax...
CRA is a proud sponsor of the event encompassing two days of practical sessions on international tax topics, with eminent speakers joining from private...
